Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study

Tara A Shrout1,2, Stephanie Pan3, Gary F Mitchell4

  • 1Department of Internal Medicine, Residency Program, Boston Medical Center, Boston, MA, United States of America.

Plos One
|April 22, 2022
PubMed

Insights

Orthostatic hypotension (OH), a drop in blood pressure upon standing, is linked to increased heart failure (HF) risk, particularly HF with reduced ejection fraction (HFrEF). Orthostatic hypertension (OHT) showed no association with HF risk.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Heart Failure Studies

Background:

  • Orthostatic hypotension (OH) and orthostatic hypertension (OHT) are abnormal blood pressure (BP) regulation conditions.
  • These conditions are associated with increased cardiovascular disease risk.
  • The relationship between OH, OHT, and heart failure (HF) risk, including its subtypes (HF with reduced ejection fraction [HFrEF] and HF with preserved ejection fraction [HFpEF]), is not well-established in community settings.

Purpose of the Study:

  • To investigate the association between OH and OHT and the risk of developing HF.
  • To examine the relationship between OH and OHT with specific HF subtypes: HFrEF and HFpEF.
  • To determine if orthostatic BP responses can serve as an early indicator for HF risk.

Main Methods:

  • A prospective observational cohort study was conducted using community-based individuals from the Framingham Heart Study Original Cohort.
  • 1,914 participants were followed from examination cycle 17 (1981-1984) until December 31, 2017, for incident HF or death.
  • OH and OHT were defined by specific BP changes upon standing; Cox proportional hazards regression models were used to analyze the associations, adjusting for multiple covariates.

Main Results:

  • During a median follow-up of 13 years, 492 HF events were observed.
  • Participants with OH exhibited a significantly higher risk of HF (Hazard Ratio [HR] 1.47, 95% CI 1.13-1.91) compared to those with normal BP response.
  • OH was specifically associated with an increased risk of HFrEF (HR 2.21, 95% CI 1.34-3.67), while OHT was not significantly associated with HF risk.

Conclusions:

  • Orthostatic hypotension may serve as an early warning sign for heart failure risk.
  • The findings suggest a potential shared pathophysiology between abnormal BP regulation (specifically OH) and the development of HF, including HFrEF.
  • Further research into the mechanisms linking orthostatic BP dysregulation and HF is warranted.
Abstract

Related Concept Videos

Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
1.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
55
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
78
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
95
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
451